| 000 | 01107 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517145719.0 | ||
| 264 | 0 | _c20170724 | |
| 008 | 201707s 0 0 eng d | ||
| 022 | _a1744-7666 | ||
| 024 | 7 |
_a10.1080/14656566.2017.1316377 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aScreever, Elles M | |
| 245 | 0 | 0 |
_aNew developments in the pharmacotherapeutic management of heart failure in elderly patients: concerns and considerations. _h[electronic resource] |
| 260 |
_bExpert opinion on pharmacotherapy _cMay 2017 |
||
| 300 |
_a645-655 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCardiotonic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aQuality of Life |
| 700 | 1 | _aMeijers, Wouter C | |
| 700 | 1 | _avan Veldhuisen, Dirk J | |
| 700 | 1 | _ade Boer, Rudolf A | |
| 773 | 0 |
_tExpert opinion on pharmacotherapy _gvol. 18 _gno. 7 _gp. 645-655 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/14656566.2017.1316377 _zAvailable from publisher's website |
| 999 |
_c27047414 _d27047414 |
||